Loading
Latest filing published 14 Sept 2021 for NantHealth, Inc., €3,405.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Ronald Allen Louks is a declared insider of NantHealth, Inc. (chief executive), with filings sourced from SEC (Form 4). Between 6 October 2017 and 13 September 2021, the trades on record add up to 58 filings.
On the market, this insider has only sold: 19 sales, €612k in total. Other entries cover 17 share grants and 22 option exercises. In 2021 alone, the filings show no purchases and 6 sales.
The latest filing, published on 14 September 2021, reports an option exercise of €4,285 in NantHealth, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations